You have activated the high contrast version of the site. For more info on this topic, please visit this page.

"CURRENT AND FUTURE PERSPECTIVES ON CHECKPOINT INHIBITORS FOR THE TREATMENT OF PATIENTS WITH NSCLC"

Share Print
-
Medical symposia
Intervenants
Paul Baas (Professeur, THE NETHERLANDS CANCER INSTITUTE, AMSTERDAM, NL)
Lieu

Salles des colloques E1-E2
Bâtiment B, niveau P
Entrée
Gratuite
Fichiers joints
Annonce_colloque_du_08_02_17_ppt.pdf
Contact
paule.mangeat@hcuge.ch
Last update : 08/02/2017